These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2173370

  • 1. Parkinson's disease beginning before age 40.
    Gershanik OS, Nygaard TG.
    Adv Neurol; 1990; 53():251-8. PubMed ID: 2173370
    [No Abstract] [Full Text] [Related]

  • 2. The Lewy body in Parkinson's disease.
    Forno LS.
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of Parkinson's disease 2008].
    Deuschl G.
    MMW Fortschr Med; 2008 May 19; 150 Suppl 2():60-3. PubMed ID: 18678055
    [No Abstract] [Full Text] [Related]

  • 4. "Minimal change" multiple system atrophy.
    Wenning GK, Quinn N, Magalhăes M, Mathias C, Daniel SE.
    Mov Disord; 1994 Mar 19; 9(2):161-6. PubMed ID: 8196676
    [Abstract] [Full Text] [Related]

  • 5. The neuromythology of Parkinson's Disease.
    Calne DB, Mizuno Y.
    Parkinsonism Relat Disord; 2004 Jul 19; 10(5):319-22. PubMed ID: 15196512
    [Abstract] [Full Text] [Related]

  • 6. Pure akinesia due to lewy body Parkinson's disease: a case with pathology.
    Quinn NP, Luthert P, Honavar M, Marsden CD.
    Mov Disord; 1989 Jul 19; 4(1):85-9. PubMed ID: 2538728
    [Abstract] [Full Text] [Related]

  • 7. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD, Arai M, Cohen JA, Trojanowski JQ.
    J Comp Neurol; 1993 Mar 15; 329(3):328-36. PubMed ID: 8459049
    [Abstract] [Full Text] [Related]

  • 8. Autosomal dominant Lewy-body Parkinson's disease.
    Golbe LI, Miller DC, Duvoisin RC.
    Adv Neurol; 1990 Mar 15; 53():287-92. PubMed ID: 2173372
    [No Abstract] [Full Text] [Related]

  • 9. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
    Qualman SJ, Haupt HM, Yang P, Hamilton SR.
    Gastroenterology; 1984 Oct 15; 87(4):848-56. PubMed ID: 6088351
    [Abstract] [Full Text] [Related]

  • 10. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
    Gibb WR, Fearnley JM, Lees AJ.
    Adv Neurol; 1990 Oct 15; 53():31-4. PubMed ID: 2173373
    [No Abstract] [Full Text] [Related]

  • 11. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease.
    Attems J, Jellinger KA.
    Neuropathol Appl Neurobiol; 2008 Aug 15; 34(4):466-7. PubMed ID: 18282157
    [No Abstract] [Full Text] [Related]

  • 12. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 13. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.
    Pappolla MA, Shank DL, Alzofon J, Dudley AW.
    Hum Pathol; 1988 Jan 19; 19(1):27-31. PubMed ID: 2447008
    [Abstract] [Full Text] [Related]

  • 14. [The neuropathology of Parkinson syndrome].
    Gray F.
    Rev Neurol (Paris); 1988 Jan 19; 144(4):229-48. PubMed ID: 2843979
    [Abstract] [Full Text] [Related]

  • 15. [Importance of magnetic resonance in Parkinson disease. An analytic study of the pars compacta].
    Maurício JC, Coelho H, Sá J, Martins A.
    Acta Med Port; 1990 Jan 19; 3(2):85-8. PubMed ID: 2349893
    [Abstract] [Full Text] [Related]

  • 16. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A.
    Neuroreport; 2006 Jul 31; 17(11):1215-8. PubMed ID: 16837857
    [Abstract] [Full Text] [Related]

  • 17. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR, Mann DM, Mountjoy CQ, Lees AJ.
    Adv Neurol; 1990 Jul 31; 53():55-9. PubMed ID: 2173375
    [No Abstract] [Full Text] [Related]

  • 18. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT, Nuyan O, Tunc T, Yorubulut M, Unal AE, Inan LE.
    Neurol India; 2004 Sep 31; 52(3):332-7. PubMed ID: 15472421
    [Abstract] [Full Text] [Related]

  • 19. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K, Takahashi H, Oyanagi K, Ikuta F.
    No To Shinkei; 1993 Nov 31; 45(11):1033-8. PubMed ID: 8135950
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.